Targeted Delivery Platform of sC3, a Complement Depleting Protein, Using Viral Delivery, Conjugate Guidance, & Localized Application Modalities

Time: 3:00 pm
day: Day Two


  • Discover how specific cell types in the retina and kidney can be targeted to express sC3
  • Conjugate guidance and tissue specific local delivery are being developed to increase efficacy and decrease off target effects
  • Taken together, these technologies allow Cascade to optimize treatment based on the therapeutic target